Active Compound in Popular Heartburn Drug Pepcid Being Tested for COVID-19 Treatment
|
By HospiMedica International staff writers Posted on 29 Apr 2020 |
|
Illustration
A trial for famotidine, the active compound in the over-the-counter heartburn medication Pepcid, is underway at the Feinstein Institutes for Medical Research (Manhasset, NY, USA) to study if the drug can make a difference in the treatment of COVID-19 patients.
The researchers decided to conduct a drug trial for famotidine after encouraging reports from China. A review of 6,212 COVID-19 patient records revealed that a large number of survivors had been experiencing chronic heartburn and were taking famotidine instead of omeprazole (Prilosec) which is more expensive and preferred in the US and among the wealthier population in China. Hospitalized COVID-19 patients who were taking famotidine seemed to have a lower death rate of 14% as against 27% for patients who were not taking the drug.
Additionally, molecular modeling results also suggested that famotidine, which appears to bind to a key enzyme in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could deliver results. Famotidine is believed to bind to an enzyme critical to COVID-19. Similar to how protease inhibitors, which are used to treat HIV, stop the virus, famotidine’s structure can stop the coronavirus from replicating, at least theoretically.
The Feinstein Institutes for Medical Research received clearance from the US Food and Drug Administration to conduct a trial using the intravenous version of famotidine. In addition to Gilead Sciences’ remdesivir and the anti-malarial drug hydroxychloroquine, the researchers are now also assessing famotidine in a small clinical trial which has enrolled 187 critical COVID-19 patients so far, including several on ventilators, and aims for a total of 1174 people. In the trial the patients are being intravenously administered nine times the amount of famotidine that a person would normally take to treat heartburn,
The researchers have been keeping the clinical trial of famotidine under wraps to ensure sufficient supply for their study, as well as avoid a rush to medication stores for the drug which would deny people with heartburn or stomach ulcers access to the drug.
Related Links:
Feinstein Institutes for Medical Research
The researchers decided to conduct a drug trial for famotidine after encouraging reports from China. A review of 6,212 COVID-19 patient records revealed that a large number of survivors had been experiencing chronic heartburn and were taking famotidine instead of omeprazole (Prilosec) which is more expensive and preferred in the US and among the wealthier population in China. Hospitalized COVID-19 patients who were taking famotidine seemed to have a lower death rate of 14% as against 27% for patients who were not taking the drug.
Additionally, molecular modeling results also suggested that famotidine, which appears to bind to a key enzyme in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could deliver results. Famotidine is believed to bind to an enzyme critical to COVID-19. Similar to how protease inhibitors, which are used to treat HIV, stop the virus, famotidine’s structure can stop the coronavirus from replicating, at least theoretically.
The Feinstein Institutes for Medical Research received clearance from the US Food and Drug Administration to conduct a trial using the intravenous version of famotidine. In addition to Gilead Sciences’ remdesivir and the anti-malarial drug hydroxychloroquine, the researchers are now also assessing famotidine in a small clinical trial which has enrolled 187 critical COVID-19 patients so far, including several on ventilators, and aims for a total of 1174 people. In the trial the patients are being intravenously administered nine times the amount of famotidine that a person would normally take to treat heartburn,
The researchers have been keeping the clinical trial of famotidine under wraps to ensure sufficient supply for their study, as well as avoid a rush to medication stores for the drug which would deny people with heartburn or stomach ulcers access to the drug.
Related Links:
Feinstein Institutes for Medical Research
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hybrid Arch Device
Neo EDE
Radiofrequency Generator
GX1
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions
Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more
Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI
Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more
Critical Care
view channel
Drone AED Delivery Could Shorten Time to Out-of-Hospital Cardiac Arrest Defibrillation
Out-of-hospital cardiac arrest requires prompt cardiopulmonary resuscitation and defibrillation. Yet automated external defibrillators (AEDs) may be difficult to reach quickly, particularly in rural areas... Read more
Wearable Patch Tracks Sleep Apnea and Chronic Respiratory Disease
Obstructive sleep apnea (OSA) requires overnight polysomnography, a test that uses many wired sensors and is difficult to repeat at home. Chronic respiratory diseases such as asthma, chronic obstructive... Read more
Surgical Techniques
view channel
First Human Implant Performed With New Open Mitral Annuloplasty Ring
In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more
Handheld Device Improves Targeted Cell Collection for Early Ovarian Cancer Assessment
High-grade serous ovarian cancer is the most common form of ovarian cancer, and many cases are thought to originate in the fallopian tubes. Because precursor lesions can be microscopic, they are difficult... Read more
Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses
Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more
FDA Approves First Sirolimus Drug-Eluting Balloon for Coronary In-Stent Restenosis
Coronary in-stent restenosis (ISR) accounts for about 10% of the nearly one million percutaneous coronary interventions performed annually in the United States. Treating recurrent narrowing without another... Read morePatient Care
view channel
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read more
Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
Anxiety and claustrophobia—intense fear of confined spaces—often prevent patients from completing cardiac positron emission tomography/computed tomography (PET/CT). Aborted scans delay diagnosis, consume... Read more
Medical Imaging
view channel
AI Tool Improves Early Detection of Silicosis and Black Lung on X-Rays
Black lung and silicosis are forms of lasting lung damage that can develop after years of inhaling coal or rock dust. More than 2.2 million U.S. workers inhale these particles on the job, and damage may... Read more
New MRI Approach Captures Rapidly Decaying Tissue Signals
MRI measures signals generated as excited proton spins return toward equilibrium. However, some tissue signals decay so rapidly that conventional systems can miss them during the brief interval after excitation,... Read more
Health IT
view channel
New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
Continuity and intensity of neurorehabilitation after stroke are critical for functional recovery, but access to ongoing therapy at home often remains limited. Hospitals and outpatient programs therefore... Read more
Smartphone App Improves Blood Pressure Control in Hypertension
Hypertension, or high blood pressure, is a major modifiable driver of cardiovascular, renal, and cerebrovascular morbidity. Despite effective therapies, many adults fail to achieve control, leading to... Read more
Point of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Business
view channel
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
Intuitive (Sunnyvale, CA, USA) announced that it has received CE mark approval for use of the da Vinci SP Single Port surgical system in transvaginal gynecologic procedures, marking the first such indication... Read more
